Why is Pseudomonas aeruginosa a pathogen?

F1000 Biology Reports

Volumn 2, Issue 1, 2010, Pages

  Goldberg, Joanna B ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; BACTERIAL VIRULENCE; DEFENSE MECHANISM; HOST RESISTANCE; HUMAN; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; REVIEW;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 77955066569     PISSN: 17404118     EISSN: 1757594X     Source Type: Journal    
DOI: 10.3410/B2-29     Document Type: Review

References (41)

1. Scarff JM, Goldberg JB: Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice. Clin Vaccine Immunol 2008, 15:367-75.
2. Allewelt M, Coleman FT, Grout M, Priebe GP, Pier GB: Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect Immun 2000, 68:3998-4004. (Pubitemid 30434552)
3. Koh AY, Priebe GP, Pier GB: Virulence of Pseudomonas aeruginosa in a murine model of gastrointestinal colonization and dissemination in neutropenia. Infect Immun 2005, 73:2262-72.
4. Hauser AR, Cobb E, Bodi M, Mariscal D, Valles J, Engel JN, Rello J: Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 2002, 30:521-8. (Pubitemid 34214611)
5. Schulert GS, Feltman H, Rabin SD, Martin CG, Battle SE, Rello J, Hauser AR: Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J Infect Dis 2003, 188:1695-706.
6. El Solh AA, Akinnusi ME, Wiener-Kronish JP, Lynch SV, Pineda LA, Szarpa K: Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia. Am J Respir Crit Care Med 2008, 178:513-9.
7. Diaz MH, Shaver CM, King JD, Musunuri S, Kazzaz JA, Hauser AR: Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect Immun 2008, 76:4414-21.
8. Koh AY, Priebe GP, Ray C, Van Rooijen N, Pier GB: Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infect Immun 2009, 77:5300-10.
9. Sun L, Guo RF, Newstead MW, Standiford TJ, Macariola DR, Shanley TP: Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge. Am J Respir Cell Mol Biol 2009, 41:76-84.
10. Downey DG, Bell SC, Elborn JS: Neutrophils in cystic fibrosis. Thorax 2009, 64:81-8.
11. Doring G, Gulbins E: Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease. Cell Microbiol 2009, 11:208-16.
12. Hassett DJ, Korfhagen TR, Irvin RT, Schurr MJ, Sauer K, Lau GW, Sutton MD, Yu H, Hoiby N: Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies. Expert Opin Ther Targets 2010, 14:117-30.
13. McKeon DJ, Cadwallader KA, Idris S, Cowburn AS, Pasteur MC, Barker H, Haworth CS, Bilton D, Chilvers ER, Condliffe AM: Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation. Eur Respir J 2009, [Epub ahead of print].
14. Adib-Conquy M, Pedron T, Petit-Bertron AF, Tabary O, Corvol H, Jacquot J, Clement A, Cavaillon JM: Neutrophils in cystic fibrosis display a distinct gene expression pattern. Mol Med 2008, 14:36-44.
15. Hirche TO, Benabid R, Deslee G, Gangloff S, Achilefu S, Guenounou M, Lebargy F, Hancock RE, Belaaouaj A: Neutrophil elastase mediates innate host protection against Pseudomonas aeruginosa. J Immunol 2008, 181:4945-54.
16. Benarafa C, Priebe GP, Remold-O'Donnell E: The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection. J Exp Med 2007, 204:1901-9.
17. Painter RG, Bonvillain RW, Valentine VG, Lombard GA, LaPlace SG, Nauseef WM, Wang G: The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils. J Leukoc Biol 2008, 83:1345-53.
18. Koller B, Kappler M, Latzin P, Gaggar A, Schreiner M, Takyar S, Kormann M, Kabesch M, Roos D, Griese M, Hartl D: TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J Immunol 2008, 181:2753-63.
19. Sonawane A, Jyot J, During R, Ramphal R: Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in Pseudomonas aeruginosa. Infect Immun 2006, 74:6682-9.
20. Koller B, Bals R, Roos D, Korting HC, Griese M, Hartl D: Innate immune receptors on neutrophils and their role in chronic lung disease. Eur J Clin Invest 2009, 39:535-47.
21. Hartl D, Latzin P, Hordijk P, Marcos V, Rudolph C, Woischnik M, Krauss-Etschmann S, Koller B, Reinhardt D, Roscher AA, Roos D, Griese M: Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007, 13:1423-30.
22. Sabroe I, Whyte MK: Incapacitating the immune system in cystic fibrosis. Nat Med 2007, 13:1417-8. (Pubitemid 350224237)
23. Van Delden C: Virulence factors in Pseudomonas aeruginosa. In Pseudomonas. Vol. 2. Edited by Ramos J-L. New York: Kluwer Academic/Plenum Publishers; 2004:3-45.
24. Van Gennip M, Christensen LD, Alhede M, Phipps R, Jensen PØ, Christophersen L, Pamp SJ, Moser C, Mikkelsen PJ, Koh AY, Tolker-Nielsen T, Pier GB, Høiby N, Givskov M, Bjarnsholt T: Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes. APMIS 2009, 117:537-46.
25. Alhede M, Bjarnsholt T, Jensen PØ, Phipps RK, Moser C, Christophersen L, Christensen LD, van Gennip M, Parsek M, Høiby N, Rasmussen TB, Givskov M: Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology 2009, 155:3500-8.
26. Cornelis P: Shielding, a new pathogen defence mechanism against PMNs. Microbiology 2009, 155:3474-5.
27. Mulcahy H, Charron-Mazenod L, Lewenza S: Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog 2008, 4:e1000213.
28. Ma L, Conover M, Lu H, Parsek MR, Bayles K, Wozniak DJ: Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog 2009, 5:e1000354.
29. Parks QM, Young RL, Poch KR, Malcolm KC, Vasil ML, Nick JA: Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J Med Microbiol 2009, 58:492-502.
30. Tolker-Nielsen T, Hoiby N: Extracellular DNA and F-actin as targets in antibiofilm cystic fibrosis therapy. Future Microbiol 2009, 4:645-7.
31. Wolfgang MC, Kulasekara BR, Liang X, Boyd D, Wu K, Yang Q, Miyada CG, Lory S: Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 2003, 100:8484-9.
32. Ernst RK, D'Argenio DA, Ichikawa JK, Bangera MG, Selgrade S, Burns JL, Hiatt P, McCoy K, Brittnacher M, Kas A, Spencer DH, Olson MV, Ramsey BW, Lory S, Miller SI: Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environ Microbiol 2003, 5:1341-9.
33. Mena A, Smith EE, Burns JL, Speert DP, Moskowitz SM, Perez JL, Oliver A: Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J Bacteriol 2008, 190:7910-7.
34. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, Burns JL, Kaul R, Olson MV: Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 2006, 103:8487-92.
35. Mathee K, Narasimhan G, Valdes C, Qiu X, Matewish JM, Koehrsen M, Rokas A, Yandava CN, Engels R, Zeng E, Olavarietta R, Doud M, Smith RS, Montgomery P, White JR, Godfrey PA, Kodira C, Birren B, Galagan JE, Lory S: Dynamics of Pseudomonas aeruginosa genome evolution. Proc Natl Acad Sci U S A 2008, 105:3100-5.
36. Balasubramanian D, Mathee K: Comparative transcriptome analyses of Pseudomonas aeruginosa. Hum Genomics 2009, 3:349-61.
37. Oberhardt MA, Puchalka J, Fryer KE, Martins dos Santos VA, Papin JA: Genome-scale metabolic network analysis of the opportunistic pathogen Pseudomonas aeruginosa PAO1. J Bacteriol 2008, 190:2790-803.
38. Lee S,Hinz A, Bauerle E, AngermeyerA, Juhaszova K, Kaneko Y, Singh PK, Manoil C: Targeting a bacterial stress response to enhance antibiotic action. Proc Natl Acad Sci U S A 2009, 106:14570-5.
39. Sadikot RT, Blackwell TS, Christman JW, Prince AS: Pathogen-host interaction in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 2005, 171:1209-23.
40. McConnell KW, McDunn JE, Clark AT, Dunne WM, Dixon DJ, Turnbull IR, Dipasco PJ, Osberghaus WF, Sherman B, Martin JR, Walter MJ, Cobb JP, Buchman TG, Hotchkiss RS, Coopersmith CM: Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses. Crit Care Med 2010, 38:223-41.
41. Kobayashi SD, Sturdevant DE, DeLeo FR: Genome-scale transcript analyses in human neutrophils. Methods Mol Biol 2007, 412:441-53.